Literature DB >> 23787527

Analysis of serum lipid profile in cholelithiasis patients.

H Batajoo1, N K Hazra.   

Abstract

BACKGROUND: Gallstone diseases being common disorder, multiple studies have shown an association between gallstones and abnormal lipids. This study is to compare the serum lipid abnormalities in females who have cholelithiasis with controls.
METHODS: A retrospective study of females who underwent cholecystectomy for gallstone disease was carried out. A total of 133 patients were divided into two age groups ≤ 40 and >40 years. In age group ≤ 40 years, there were 72 cases with no controls, whereas, in >40 years, 61 cases were compared with 67 controls. The serum lipid profile were collected and compared according to the age groups. The groups were compared by using Student's t-test, p<0.05 was considered statistically significant.
RESULTS: In age group >40 years serum LDL of gallstone patients were statistically significantly raised (P<0.05) (95% CI -22.077; -850) compared with controls and serum total cholesterol and triglycerides were not statistically significantly high (P >0.05). Serum HDL and VLDL were lower in gallstone patients but not statistically significant (P >0.05) compared to control group.
CONCLUSIONS: The study showed that serum LDL level was statistically significant in females >40 years of age, whereas other parameters were not statistically significantly different.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787527

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  2 in total

1.  Comparative analysis of serum lipid profiles in patients with and without gallstones: A prospective cross-sectional study.

Authors:  Sikandar Hayat; Zarbakht Hassan; Shabbar Hussain Changazi; Anam Zahra; Muhammad Noman; Muhammad Zain Ul Abdin; Haris Javed; Armghan Haider Ans
Journal:  Ann Med Surg (Lond)       Date:  2019-04-24

Review 2.  Risk Factors for Cholelithiasis.

Authors:  Mila Pak; Glenda Lindseth
Journal:  Gastroenterol Nurs       Date:  2016 Jul-Aug       Impact factor: 0.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.